Ursprung des Netzwerks ersten Grades von Sander Bangma
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sander Bangma
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Adelaide | College/University | Doctorate Degree | |
| University of Ballarat | College/University | Undergraduate Degree | |
| BATTERY AGE MINERALS LTD | Steel | Director of Finance/CFO | |
| VIRIDIS MINING AND MINERALS LIMITED | Precious Metals | Chairman | |
| EQUINOX RESOURCES LIMITED | Steel | Director/Board Member | |
| LONESTAR RESOURCES US INC. | Integrated Oil | Director/Board Member | |
| Invex Therapeutics Ltd. (United Kingdom) | Director/Board Member | ||
| Warambi Ltd. | Corporate Officer/Principal | ||
| INVEX THERAPEUTICS LTD | Biotechnology | Founder | |
| The University of New South Wales | College/University | Undergraduate Degree | |
| 4SC AG | Biotechnology | Chief Executive Officer | |
Corticrine Ltd.
 Corticrine Ltd. Pharmaceuticals: MajorHealth Technology Part of Actinogen Medical Ltd., Corticrine Ltd. develops and manufactures drugs. The company is based in Edinburgh, UK. Corticrine was acquired by Actinogen Medical Ltd. on December 01, 2014 for $4.97 million. | Pharmaceuticals: Major | Director/Board Member | |
| ACTINOGEN MEDICAL LIMITED | Pharmaceuticals: Other | Chairman | |
| JDS BioPharma Pty Ltd. | Director/Board Member | ||
| Warambi SARL | Director/Board Member | ||
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer | |
Parvulus Suisse SA
 Parvulus Suisse SA Medical SpecialtiesHealth Technology Parvulus Suisse SA provides medical technology. It focused on commercializing devices for cardiac surgery distribution, manufacturing, sales and distribution. The company was founded in March 20011 and is headquartered in Lonay, Switzerland. | Medical Specialties | Chief Executive Officer | |
| BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
| Korda & Co. | Investment Managers | Chief Investment Officer | |
| PIONEER LITHIUM LIMITED | Other Metals/Minerals | Director/Board Member |
Statistik
International
| Australien | 14 |
| Vereinigtes Königreich | 8 |
| Frankreich | 5 |
| Deutschland | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 10 |
| Non-Energy Minerals | 5 |
| Energy Minerals | 5 |
| Finance | 4 |
| Consumer Services | 4 |
Operativ
| Director/Board Member | 19 |
| Corporate Secretary | 6 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jason Loveridge | 20 |
| Agha Pervez | 6 |
| Mitchell Wells | 3 |
| Adrian R. Bowers | 3 |
| Melanie Baxter | 1 |
| Celine Royet | 1 |
| Travis Baroni | 1 |
| Emma Stone | 1 |
- Börse
- Insiders
- Sander Bangma
- Unternehmensverbindungen
